IC
REGN icon

IEQ Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

IEQ Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30M Sell
48,105
-30,197
-39% -$20.6M 0.14% 130
2026
Q1 		$60.5M Buy
78,302
+9,665
+14% +$7.4M 0.28% 66
2025
Q4 		$53M Buy
68,637
+24,977
+57% +$17M 0.16% 77
2025
Q3 		$24.5M Buy
43,660
+39,747
+1,016% +$22.5M 0.07% 138
2025
Q2 		$2.05M Sell
3,913
-4,306
-52% -$2.4M 0.01% 634
2025
Q1 		$5.21M Buy
8,219
+4,381
+114% +$3.01M 0.04% 332
2024
Q4 		$2.73M Sell
3,838
-1,496
-28% -$1.26M 0.03% 422
2024
Q3 		$5.61M Sell
5,334
-197
-4% -$219K 0.07% 183
2024
Q2 		$5.81M Buy
5,531
+507
+10% +$491K 0.08% 164
2024
Q1 		$4.84M Buy
5,024
+585
+13% +$556K 0.07% 185
2023
Q4 		$3.9M Buy
4,439
+990
+29% +$815K 0.06% 188
2023
Q3 		$2.84M Buy
3,449
+103
+3% +$80.9K 0.06% 201
2023
Q2 		$2.4M Buy
3,346
+73
+2% +$56.3K 0.05% 235
2023
Q1 		$2.69M Sell
3,273
-299
-8% -$226K 0.06% 205
2022
Q4 		$2.58M Buy
3,572
+336
+10% +$248K 0.07% 198
2022
Q3 		$2.23M Buy
3,236
+744
+30% +$468K 0.06% 213
2022
Q2 		$1.47M Buy
2,492
+324
+15% +$211K 0.04% 246
2022
Q1 		$1.51M Buy
2,168
+407
+23% +$257K 0.04% 255
2021
Q4 		$1.11M Sell
1,761
-63
-3% -$38.7K 0.03% 285
2021
Q3 		$1.1M Buy
1,824
+819
+81% +$508K 0.03% 281
2021
Q2 		$561K Buy
1,005
+427
+74% +$216K 0.02% 342
2021
Q1 		$273K Buy
+578
New +$281K 0.01% 383
2020
Q4 		– Sell
-767
Closed -$429K – 354
2020
Q3 		$429K Buy
767
+1
+0.1% +$606 0.02% 252
2020
Q2 		$478K Hold
766
– – 0.03% 204
2020
Q1 		$373K Buy
766
+94
+14% +$38.8K 0.03% 244
2019
Q4 		$253K Buy
+672
New +$226K 0.02% 345

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

IEQ Capital's REGN Position: Q2 2026 in Review

IEQ Capital reduced its Regeneron Pharmaceuticals (REGN) stake by 39% in Q2 2026, selling an estimated $20.6M and leaving 48,105 shares worth $30M. The position accounts for 0.14% of the portfolio, ranked #130.

IEQ Capital first reported a position in REGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $60.5M in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • IEQ Capital held 48,105 shares of Regeneron Pharmaceuticals worth $30M as of Q2 2026.
  • IEQ Capital sold 30,197 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $20.6M.
  • Regeneron Pharmaceuticals made up 0.14% of IEQ Capital's portfolio in Q2 2026, its #130 holding.
  • IEQ Capital first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 26 quarters since.
  • IEQ Capital's Regeneron Pharmaceuticals position peaked at $60.5M in Q1 2026.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.